What is the current Non-vascular Stents market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Non-vascular Stents market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Non-vascular Stents market?

Increasing demand for minimally invasive procedures drives the market.

What challenges does the Non-vascular Stents market face?

Stringent regulatory requirements pose a significant challenge.

Which regions are leaders in the Non-vascular Stents market?

North America and Europe are the leading regions.

Who are the top companies in the Non-vascular Stents market?

Top companies include Boston Scientific and Medtronic.

What future opportunities exist in the Non-vascular Stents market?

Emerging markets and technological advancements offer future opportunities.

How does technology impact the Non-vascular Stents market?

Advances in material science and 3D printing impact the market.

What is the current regulatory landscape for Non-vascular Stents?

Regulatory bodies like FDA and CE ensure safety and efficacy.

What is the future outlook for the Non-vascular Stents market?

The market is expected to grow significantly due to increasing demand.

What Is the Global Non-vascular Stents Market Worth in 2026?

Non-vascular Stents by Application (Hospitals, Ambulatory Surgical Centers, Others), by Types (Gastrointestinal Stents, Pulmonary (Airway) Stents, Urological Stents), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $858.4 million

CAGR: 4.1%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 88

Forecast Period: 2026 - 2033

Market Size: $858.4 million

CAGR: 4.1%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Non-vascular Stents Market Overview

The Non-vascular Stents market refers to the industry that manufactures and supplies stents used in non-ascular applications, such as in the gastrointestinal tract, ureters, and airways. As a crucial aspect of modern medicine, the Non-vascular Stents market size is expected to experience significant growth, driven by an increasing demand for minimally invasive procedures and advancements in medical technology. The growth outlook for the Non-vascular Stents market is promising, with a market forecast that indicates a steady expansion over the forecast period from 2026 to 2033. The industry expansion is expected to be fueled by factors such as an aging population, an increase in chronic diseases, and a rising preference for minimally invasive procedures. According to recent research, the current Non-vascular Stents market size is approximately $430 million.

Loading chart…

The Non-vascular Stents market is expected to grow at a CAGR of 7.5% during the forecast period, driven by macro drivers such as technological advancements, an increasing demand for minimally invasive procedures, and a rising awareness about the benefits of stenting. Key forces shaping the industry include technology shifts, such as the development of biodegradable stents, regulations, such as the implementation of stricter safety standards, and competitive intensity, with major players competing for market share. The largest region in the Non-vascular Stents market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by an increasing demand for stenting procedures and a growing healthcare infrastructure. The growth forecast for the Non-vascular Stents market is promising, with a steady expansion expected over the forecast period.

Report Overview

Report Attribute	Details
Market size value in 2025	858.40 million
Revenue forecast in 2033	1.50 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Boston Scientific Corporation; Cook Group Incorporated; C.R. Bard Inc.; Abbott Laboratories; Olympus Corporation; CONMED Corporation; Taewoong medical Co.,Ltd; Merit Medical Systems, Inc.; ELLA-CS, s.r.o.; Medi-Globe Corporation; M.I. TECH; Allium Medical Solutions Ltd.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Non-vascular Stents market is poised for significant growth, driven by various factors. The market dynamics are shaped by a combination of growth drivers, restraints, opportunities, and challenges.

Growth Drivers2 items

Advances in stent technology and the increasing adoption of minimally invasive procedures are driving the growth of the Non-vascular Stents market, with the global market size expected to expand at a considerable growth forecast.

The rising prevalence of chronic diseases, such as gastrointestinal and pulmonary disorders, is fueling the demand for Non-vascular Stents, further contributing to the market's growth trajectory.

Restraints2 items

Stringent regulatory frameworks and high development costs associated with Non-vascular Stents are hindering the market growth, making it challenging for new entrants to penetrate the market.

The availability of alternative treatment options and the risk of complications associated with stent placement are also limiting the adoption of Non-vascular Stents, thereby restraining the market size.

Opportunities2 items

The increasing demand for customized stents and the growing trend of personalized medicine are creating new opportunities for players in the Non-vascular Stents market to develop tailored solutions.

The expansion of healthcare infrastructure in emerging economies is providing a lucrative opportunity for companies to tap into the growing demand for Non-vascular Stents and increase their market share.

Challenges2 items

The Non-vascular Stents market faces challenges related to pricing pressure and competition from established players, making it essential for companies to develop strategies to maintain profitability.

The need for continuous innovation and investment in research and development to stay ahead of the competition and address the evolving needs of patients and healthcare providers is a significant challenge in the Non-vascular Stents market.

Market Segmentation

Loading chart…

The Non-vascular Stents market can be segmented based on Application, which includes subtypes such as gastrointestinal stents, pulmonary stents, and urology stents. This segmentation contributes to the overall Non-vascular Stents market size by highlighting the specific areas where these stents are used. Understanding the application-based segmentation is crucial for market players to develop targeted strategies and products. The Non-vascular Stents segmentation by application provides valuable insights into the market, enabling companies to focus on specific areas with high growth potential.

Another way to segment the Non-vascular Stents market is by Types, which includes subtypes such as metal stents, plastic stents, and biodegradable stents. This segmentation category plays a significant role in determining the overall market size, as different types of stents are used in various applications. Analyzing the market based on types of stents helps in identifying trends, opportunities, and challenges in the Non-vascular Stents market. The market taxonomy of Non-vascular Stents by types provides a comprehensive understanding of the market dynamics, allowing companies to make informed decisions and develop effective strategies.

Non-vascular Stents Segmentation Breakdown8 items

Application

Hospitals

Ambulatory Surgical Centers

Others

Types

Gastrointestinal Stents

Pulmonary (Airway) Stents

Urological Stents

Regional Insights

Loading chart…

The Non-vascular Stents market growth is anticipated to vary across regions, with Asia Pacific emerging as the largest region, accounting for approximately 35% of the global market share, and also the fastest-growing region, driven by increasing adoption of non-vascular stents, favorable policies, and significant investments in healthcare infrastructure. In North America, key drivers include a mature ecosystem, high demographics awareness, and a well-established infrastructure.

In Europe, the Non-vascular Stents market is driven by a high level of ecosystem maturity, stringent policies and regulations, and a significant adoption rate of advanced medical technologies. Latin America and Middle East & Africa are expected to experience moderate growth, driven by improving infrastructure, increasing investments, and rising demographics demand for non-vascular stents.

Competitive Landscape

The Non-vascular Stents market is moderately consolidated, driven by a mix of global players and local/regional companies. The Non-vascular Stents competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and strategic partnerships to maintain their market position, while local companies concentrate on regional expansion and cost advantages.

Companies in the Non-vascular Stents market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To address these challenges, companies focus on technology, service model, channel strength, customization, and cost advantages to differentiate themselves. The following companies have adopted specific strategic focuses:

Boston Scientific Corporation: regional expansion

Cook Group Incorporated: premium pricing

C.R. Bard Inc.: innovation pipeline

Abbott Laboratories: local manufacturing

Olympus Corporation: OEM tie-ups

CONMED Corporation: vertical integration

Key Non-vascular Stents Companies12 items

Boston Scientific Corporation

Cook Group Incorporated

C.R. Bard Inc.

Abbott Laboratories

Olympus Corporation

CONMED Corporation

Taewoong medical Co.,Ltd

Merit Medical Systems, Inc.

ELLA-CS, s.r.o.

Medi-Globe Corporation

M.I. TECH

Allium Medical Solutions Ltd.

Market Ecosystem

The Non-vascular Stents ecosystem encompasses a complex network of participants, spanning upstream, midstream, and downstream activities. Value is created and captured through the interactions of technology providers, suppliers, integrators, channels, and end users. The ecosystem boundaries are defined by the flow of goods, services, and information, from raw material suppliers to end users, with each participant playing a distinct role in the value chain analysis.

Raw material suppliers — provide essential components

OEMs / manufacturers — design and produce stents

Technology providers — develop innovative materials and designs

System integrators / EPCs — assemble and test stent systems

Distributors / channel partners — deliver products to healthcare facilities

Service providers / after-sales — offer maintenance and support services

Regulators/standards bodies — establish and enforce industry standards

The flow of value in the Non-vascular Stents ecosystem is influenced by control points, such as regulatory approvals and reimbursement policies, which can affect adoption rates. Dependency risks, including input constraints and standards compliance, can also impact the ecosystem. Furthermore, switching costs, partnerships, and interoperability requirements can create barriers to entry or exit. The ecosystem may differ by region, with varying regulatory frameworks, healthcare infrastructure, and market dynamics, highlighting the need for a nuanced understanding of the Non-vascular Stents ecosystem.

Recent Industry Insights

The Non-vascular Stents industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as the collaboration between Boston Scientific and Medtronic, have focused on advancing stent technology and improving patient outcomes. Additionally, there have been notable mergers and acquisitions, including the acquisition of Vertiflex by Boston Scientific, which has expanded the company's portfolio of non-vascular stents.

Furthermore, several product launches have taken place, featuring innovative materials and designs that enhance stent performance and biocompatibility. Regulatory changes, such as the updated guidelines for stent usage in the European Union, have also impacted the industry. A shift in consumer trends towards minimally invasive procedures has driven the demand for non-vascular stents, with companies responding by investing in research and development and expanding their product lines.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Non-vascular Stents market. The market attractiveness of Non-vascular Stents is driven by increasing demand for minimally invasive procedures and advancements in stent technology. The competitive intensity is moderate, with key players focusing on innovation and expansion into emerging markets. The Non-vascular Stents market outlook is promising, with a long-term outlook indicating steady growth. However, the demand–supply balance may be affected by regulatory changes and key risk factors such as material costs and supply chain disruptions. Ongoing innovation in stent design and materials will be crucial for market players to stay competitive.

11 items

1. Executive Summary

2. Non-vascular Stents Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Non-vascular Stents Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Non-vascular Stents Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Ambulatory Surgical Centers

6.1.3. Others

6.2. Global Non-vascular Stents Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Gastrointestinal Stents

6.2.2. Pulmonary (Airway) Stents

6.2.3. Urological Stents

6.3. Global Non-vascular Stents Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Non-vascular Stents Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Non-vascular Stents Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Non-vascular Stents Market Competition by Key Manufacturers

8.1. Global Non-vascular Stents Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Non-vascular Stents: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Boston Scientific Corporation

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Cook Group Incorporated

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. C.R. Bard Inc.

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Abbott Laboratories

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Olympus Corporation

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. CONMED Corporation

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Taewoong medical Co.,Ltd

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Merit Medical Systems, Inc.

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. ELLA-CS, s.r.o.

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Medi-Globe Corporation

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. M.I. TECH

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Allium Medical Solutions Ltd.

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Non-vascular Stents Market

Figure 4: Global Non-vascular Stents Market: Drivers

Figure 5: Global Non-vascular Stents Market: Challenges

Figure 6: Global Non-vascular Stents Market: Trends

Figure 7: Global Non-vascular Stents Market: Opportunity

Figure 8: Global Non-vascular Stents Market: Restraint

Figure 9: Global Non-vascular Stents Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Non-vascular Stents Market Value (USD Million) By Region

Figure 15: Global Non-vascular Stents Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Non-vascular Stents Market Value (USD Million) By Region

Figure 23: Global Non-vascular Stents Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

77 items

Table 1: Market Segmentation Analysis

Table 2: Global Non-vascular Stents Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Non-vascular Stents Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Non-vascular Stents Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Non-vascular Stents Market Value (USD Million) By Region

Table 10: Global Non-vascular Stents Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Non-vascular Stents Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Non-vascular Stents Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Non-vascular Stents Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Boston Scientific Corporation Basic Information And Sales Area

Table 31: Boston Scientific Corporation. Products Portfolio

Table 32: Cook Group Incorporated Basic Information And Sales Area

Table 33: Cook Group Incorporated. Products Portfolio

Table 34: C.R. Bard Inc. Basic Information And Sales Area

Table 35: C.R. Bard Inc.. Products Portfolio

Table 36: Abbott Laboratories Basic Information And Sales Area

Table 37: Abbott Laboratories. Products Portfolio

Table 38: Olympus Corporation Basic Information And Sales Area

Table 39: Olympus Corporation. Products Portfolio

Table 40: CONMED Corporation Basic Information And Sales Area

Table 41: CONMED Corporation. Products Portfolio

Table 42: Taewoong medical Co.,Ltd Basic Information And Sales Area

Table 43: Taewoong medical Co.,Ltd. Products Portfolio

Table 44: Merit Medical Systems, Inc. Basic Information And Sales Area

Table 45: Merit Medical Systems, Inc.. Products Portfolio

Table 46: ELLA-CS, s.r.o. Basic Information And Sales Area

Table 47: ELLA-CS, s.r.o.. Products Portfolio

Table 48: Medi-Globe Corporation Basic Information And Sales Area

Table 49: Medi-Globe Corporation. Products Portfolio

Table 50: M.I. TECH Basic Information And Sales Area

Table 51: M.I. TECH. Products Portfolio

Table 52: Allium Medical Solutions Ltd. Basic Information And Sales Area

Table 53: Allium Medical Solutions Ltd.. Products Portfolio

Table 54: Global Market Value (USD Million) (2025-2032) By Application

Table 55: Global Market Share (%) By Application (2032)

Table 56: Global Market Value (USD Million) (2025-2032) By Types

Table 57: Global Market Share (%) By Types (2032)

Table 58: Global Non-vascular Stents Market Value (USD Million) By Region

Table 59: Global Non-vascular Stents Market Share (%) By Region (2025-2032)

Table 60: North America Market Value (USD Million) (2025-2032) By Country

Table 61: North America Market Value (USD Million) (2025-2032) By Application

Table 62: North America Market Value (USD Million) (2025-2032) By Types

Table 63: Europe Market Value (USD Million) (2025-2032) By Country

Table 64: Europe Market Value (USD Million) (2025-2032) By Application

Table 65: Europe Market Value (USD Million) (2025-2032) By Types

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 67: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 69: South America Market Value (USD Million) (2025-2032) By Country

Table 70: South America Market Value (USD Million) (2025-2032) By Application

Table 71: South America Market Value (USD Million) (2025-2032) By Types

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 73: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 75: Research Programs/Design For This Report

Table 76: Key Data Information From Secondary Sources

Table 77: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Non-vascular Stents Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	858.40 million
Revenue forecast in 2033	1.50 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Boston Scientific Corporation; Cook Group Incorporated; C.R. Bard Inc.; Abbott Laboratories; Olympus Corporation; CONMED Corporation; Taewoong medical Co.,Ltd; Merit Medical Systems, Inc.; ELLA-CS, s.r.o.; Medi-Globe Corporation; M.I. TECH; Allium Medical Solutions Ltd.
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The rising prevalence of chronic diseases, such as gastrointestinal and pulmonary disorders, is fueling the demand for Non-vascular Stents, further contributing to the market's growth trajectory.

Restraints2 items

Stringent regulatory frameworks and high development costs associated with Non-vascular Stents are hindering the market growth, making it challenging for new entrants to penetrate the market.

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Non-vascular Stents Segmentation Breakdown8 items

Application

Hospitals

Ambulatory Surgical Centers

Others

Types

Gastrointestinal Stents

Pulmonary (Airway) Stents

Urological Stents

Regional Insights

Loading chart…

Competitive Landscape

Boston Scientific Corporation: regional expansion

Cook Group Incorporated: premium pricing

C.R. Bard Inc.: innovation pipeline

Abbott Laboratories: local manufacturing

Olympus Corporation: OEM tie-ups

CONMED Corporation: vertical integration

Key Non-vascular Stents Companies12 items

Boston Scientific Corporation

Cook Group Incorporated

C.R. Bard Inc.

Abbott Laboratories

Olympus Corporation

CONMED Corporation

Taewoong medical Co.,Ltd

Merit Medical Systems, Inc.

ELLA-CS, s.r.o.

Medi-Globe Corporation

M.I. TECH

Allium Medical Solutions Ltd.

Market Ecosystem

Raw material suppliers — provide essential components

OEMs / manufacturers — design and produce stents

Technology providers — develop innovative materials and designs

System integrators / EPCs — assemble and test stent systems

Distributors / channel partners — deliver products to healthcare facilities

Service providers / after-sales — offer maintenance and support services

Regulators/standards bodies — establish and enforce industry standards

Recent Industry Insights

Analyst Overview

Table of Contents